SCHEMBL7536631

SCHEMBL7536631

COc1ccc(-c2cn(CCC(=O)O)c3cc(OC)cc(OC)c3c2=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 1/20 0.47
SENP8 Q96LD8 1/20 0.47
SENP7 Q9BQF6 1/20 0.47
SENP6 Q9GZR1 1/20 0.47
ALDH1A1 P00352 5/20 0.46
CYP3A4 P08684 4/20 0.46
KDM4E B2RXH2 3/20 0.46
HSD17B10 Q99714 3/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
EGFR P00533 3/20 0.46
KMO O15229 1/20 0.42
GAA P10253 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
TP53 P04637 2/20 0.41
MAPT P10636 2/20 0.41
THRB P10828 1/20 0.41
HPGD P15428 1/20 0.41
TUBB4A P04350 2/20 0.41
TUBB P07437 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7261259 0.90 EGFR (0.48) CASP3SENP8SENP7SENP6ALDH1A1
SCHEMBL7532023 0.89 EGFR (0.48) ALDH1A1CYP3A4KDM4EHSD17B10NPC1
SCHEMBL7537499 0.83 CASP3 (0.50) CASP3SENP8SENP7SENP6ALDH1A1
SCHEMBL7261248 0.83 ALDH1A1 (0.46) ALDH1A1CYP3A4KDM4EHSD17B10NPC1
SCHEMBL7257604 0.83 ALDH1A1 (0.46) ALDH1A1CYP3A4KDM4EHSD17B10NPC1
SCHEMBL7256772 0.82 ALDH1A1 (0.46) ALDH1A1CYP3A4KDM4EHSD17B10NPC1
SCHEMBL7256709 0.81 ALDH1A1 (0.46) ALDH1A1CYP3A4KDM4EHSD17B10NPC1
SCHEMBL7260644 0.81 EGFR (0.50) ALDH1A1CYP3A4KDM4EHSD17B10NPC1
SCHEMBL7261275 0.81 ALDH1A1 (0.45) ALDH1A1CYP3A4KDM4EHSD17B10NPC1
SCHEMBL7257558 0.80 TSPO (0.45) ALDH1A1CYP3A4KDM4EHSD17B10NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1202971-A2 PHARMACEUTICAL COMPOSITIONS COMPRISING 4-QUINOLONES LABORATOIRE L. LAFON (FR) 2002-05-08 EP disclosed
WO-2002022074-A2 USE OF 2- AND 4- QUINOLONES FOR INHIBITING INTIMAL NEO-PROLIFERATION LABORATOIRE L. LAFON (FR) 2002-03-21 WO disclosed
WO-2001012607-A2 PHARMACEUTICAL COMPOSITIONS COMPRISING 4-QUINOLONES FOR TREATING CANCERS LABORATOIRE L. LAFON (FR) 2001-02-22 WO disclosed